Related Experiment Video
Updated: Jan 18, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Temporal and Spatial Dynamics of Motor Dysfunction in Preclinical Parkinson's Disease and Aging
Navya Nair1, Grace Hey2, Alexander Becsey1
1Lillian S. Wells Department of Neurosurgery, College of Medicine, University of Florida, Gainesville, FL 32611, USA.
None:
Gait assessments have been performed in several murine models of Parkinson's Disease (PD), but the M83+/- mouse model of PD has been relatively understudied in this context. Metrics of gait swing, stride length and frequency, and ataxia were collected in M83+/- mice with peripheral injections of α-syn preformed fibrils (PFF) and in aged M83+/- mice without fibrils using the DigiGait™ system. PFF-mice showed significantly decreased swing in all limbs (0.11 ± 0.02 vs. 0.13 ± 0.03, p = 0.007) compared to age-matched controls. Stride frequency was significantly increased in all limbs (3.9 ± 0.4 vs. 3.0 ± 0.5, p = 0.010) of PFF-treated mice. Swing was significantly greater in the hindlimbs of young M83+/-+PFF mice compared to aged M83+/- mice (0.11(0.5) vs. 0.08 (0.3), p = 0.015). Ataxia was significantly higher in young M83+/-+PFF mice compared to control for forelimbs (1.1 ± 1.0 vs. 0.6 ± 0.5, p = 0.027), hindlimbs (0.9 ± 1.0 vs. 0.3 ± 0.2, p = 0.016), and all limbs (1.0 ± 1.0 vs. 0.3 ± 0.5, p = 0.015). M83+/- mice demonstrate significant gait abnormalities consistent with features of PD. This study supports the utility of the M83+/- murine model for preclinical gait analyses in PD.
More Related Videos
05:39A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
Published on: June 13, 2025
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Pharmacodynamics in Geriatric Patients: Effects of Age